Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies

PURPOSE: To determine the long-term efficacy of the anti-tumor necrosis factor (TNF) agents, infliximab (IFX) and adalimumab (ADA), in pediatric luminal Crohn's disease (CD) by performing a systematic literature review. METHODS: An electronic search was performed in Medline, Embase, and the Coc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pediatr Gastroenterol Hepatol Nutr
Autores principales: van Rheenen, Hanna, van Rheenen, Patrick Ferry
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2020
Materias:
Systemic Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7073369/
https://ncbi.nlm.nih.gov/pubmed/32206624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5223/pghn.2020.23.2.121
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares